phorylates DIAP1, leading to its degradation ( Figure 1 ). The authors first carried out a genetic screen in the fruit fly Drosophila for mutations that modify the eye-loss phenotype caused by overexpression of the proapoptotic gene reaper, which is a known antagonist of DIAP1. This led them to a previously uncharacterized gene that encodes a protein kinase, which they named DmIKKε. Overexpression of DmIKKε led to increased caspase activity and apoptotic cell death in imaginal discs. Furthermore, they found that DIAP1 protein levels were reduced in cells overexpressing DmIKKε, both in vivo and in vitro. In cultured S2 cells, DmIKKε associated with and phosphorylated DIAP1. In addition, expression of NAK (NF-κB-activating kinase)-the human ortholog of DmIKKε-in S2 cells caused depletion of DIAP1 and cell death. NAK also phosphorylated XIAP, one of the mammalian IAPs, suggesting that this relationship has been conserved during evolution.
These observations are important because they identify DmIKKε as a new determinant of IAP protein level, which can mean the difference between life and death. IAPs bind to caspases and inhibit their activities, and caspases are primary molecular arbiters of apoptosis. Proteins such as Reaper bind to DIAP1 and cause it to selfdestruct, thereby derepressing caspase activity and promoting apoptosis (Figure 1) . If the level of DIAP1 exceeds that of its antagonists, caspases will be shut down and the cell will live; otherwise, it will die.
But that is not the whole story because DIAP1 and caspases do not exist solely to inhibit cell death. DIAP1 can also promote cell migration, and caspases have been shown to control a variety of nonapoptotic functions Two new papers Oshima et al., 2006 ) describe a previously uncharacterized Drosophila kinase (DmIKKε) that regulates the abundance of DIAP1, a protein best known for its ability to inhibit apoptosis. However, DmIKKε-mediated degradation of DIAP1 does not regulate apoptosis as might be predicted but instead regulates actin dynamics, cell morphology, and the differentiation of sensory organ precursor cells. The fly protein DIAP1 is a direct inhibitor of both the apical caspase DRONC and the effector caspases that DRONC activates. A frequent consequence of such caspase activation is apoptosis. However, both apical and effector caspases have been implicated in nonapoptotic functions, such as the differentiation of sensory organ precursors , sperm individualization (Arama et al., 2003) , border cell migration (Geisbrecht and Montell, 2004) , and the morphology of sensory and tracheal cells (Oshima et al., 2006) . including cell proliferation, differentiation, morphogenesis, and migration. Nonapoptotic functions have been discovered in both mammals (Launay et al., 2005; Schwerk and Schulze-Osthoff, 2003) and Drosophila (Cashio et al., 2005) .
The new work by combines in vivo genetic experiments with biochemical analysis of proteins expressed in cultured cells to define the function of DmIKKε. Although high levels of DmIKKε expression in vivo cause apoptosis, and although reducing DmIKKε inhibited artificially induced cell death, the normal function of this kinase does not appear to be regulation of apoptosis. Reduction of DmIKKε expression does not lead to increased apoptosis in embryos or imaginal discs, even though it does reduce caspase activity. So what is the function of DmIKKε-mediated caspase activation, if not to control apoptosis? In earlier work, the same lab showed that caspase activity can be detected in imaginal disc cells that are not undergoing apoptosis and that sensory organ precursor (SOP) development depends on caspase activity but not apoptosis (Kanuka et al., 2005) . They also showed that the apical caspase DRONC can cleave and thereby activate one particular isoform of the kinase Shaggy, which participates in Wingless signaling. The new work shows that the number of SOP cells is also affected by DmIKKε through this previously defined nonapoptotic function of DRONC.
In a collaborative and complementary study recently published in Current Biology, Oshima et al. (2006) came across the same DmIKKε gene in a different genetic screen. These investigators screened for genes that, when overexpressed, caused defects in the organization of the Drosophila tracheal system, an interconnected network of tubes that constitutes the breathing system of the fly. Oshima et al. found that overexpression of DmIKKε caused loss of apical-basal polarity in tracheal epithelial cells and, as a consequence, disorganization of the tracheal network. Suspecting that the actin cytoskeleton might be involved, they directly examined the effects of inhibiting or enhancing the activity of DMIKKε on actin dynamics in cultured S2 cells. Expression of a dominant-negative kinase caused morphological changes in the cells and enhanced the stability of the actin cytoskeleton. Shrinkage of the dynamic domain of peripheral actin was also observed in ruffling cells, and, together, these observations suggested that DmIKKε might be a negative regulator of F-actin polymerization. Consistent with this notion, overexpression of the kinase destabilized the actin cytoskeleton and caused excess membrane ruffling. These effects were apparently independent of apoptosis. The investigators went on to examine the effect of manipulating DmIKKε function in specific cells in vivo, either reducing or increasing its activity. They found a variety of effects on the morphology of actin-based structures such as sensory bristles, tracheal cell protrusions, and lateral branches of the arista (thin sensory protrusions that extend off of the fly antenna). For example, DmIKKε depletion caused ectopic branching of each of these structures, a phenotype that is also observed following overexpression of well-characterized regulators of actin polymerization such as profilin. Based on genetic interactions, ectopic branching observed following depletion of DmIKKε appears to result from excess DIAP1 protein.
So how does excess DIAP1 lead to increased branching of actinrich protrusions? A previous study showed that DIAP1 overexpression suppressed defects in border cell migration that were caused by dominant-negative Rac, another well-characterized regulator of cell morphology and actin protrusions. Dominant-negative DRONC also rescued the phenotype (Geisbrecht and Montell, 2004) . Consistent with these observations, Oshima et al. (2006) found that overexpression of DIAP1 or dominant-negative DRONC enhanced the excessive branching caused by low DmIKKε.
Taken together, the new data in both papers show that DmIKKε functions as a negative regulator of DIAP1 protein levels and is thereby a positive regulator of caspase activity. The primary function of DmIKKε in vivo seems to be to promote the nonapoptotic functions of the caspase DRONC in a variety of cell types. These functions include specification of SOPs on the one hand and regulation of actin polymerization and actin-based cell morphology on the other. This intriguing new work adds to the existing literature implicating caspases and their regulators in nonapoptotic functions and raises a number of compelling questions. For example, what activates DmIKKε? One study in cultured HEK293 cells showed that the platelet-derived growth factor (PDGF) stimulates NAK activity via protein kinase C, providing one possible mechanism of activation of the mammalian homolog of DmIKKε (Tojima et al., 2000) . However, it is unclear whether this is the only activation pathway or whether there might be different inputs in different biological contexts. In keeping with this idea, NAK was originally identified as regulating the NF-κB pathway, which is not related in any obvious way to the new findings. A second question concerns the identity of the critical targets of DRONC in its nonapoptotic functions. With respect to changes in cell morphology and actin organization, the small GTPase Rac, actin, and other proteins that affect actin are known caspase targets. Which of these, if any, mediate the reported biological effects remains to be determined.
What is the unifying theme, if any, between the different biological processes that employ caspase activity? Some of the differentiation events controlled by caspases, such as lens differentiation and sperm individualization, resemble incomplete apoptosis. For example, the nucleus is extruded from differentiated lens cells, whereas in sperm individualization, the cytoplasmic volume is reduced while the nucleus is spared. In these cases, it is not difficult to imagine how the apoptotic machinery came to be involved. But what about the others? Apoptosis was originally described as a series of morphological changes. One possibility is that a subset of the morphological changes associated with apoptosis are related to normal changes that cells undergo during development. For example, apoptotic cells round up, detach from their neighbors, and undergo reorganization of the actin cytoskeleton, behaviors that also characterize motile cells leaving an epithelium. Perhaps certain cells have harnessed the activities of caspases and their regulators in order to accomplish a subset of the features of apoptosis and put them to use. But how do they survive in the presence of activated caspase? Is caspase activity physically compartmentalized so that access to substrates is very limited? Or is it simply a question of the level of caspase activity that determines how a cell responds? Perhaps the presence (or absence) of other factors limits the effects of an active caspase? Might the answers be different for different cell types? These are some of the questions that promise to keep investigators interested in life and death busy for the foreseeable future.
